William Oh

Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai

Affiliated withIcahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai

Research Area

Biography

William Oh has not added Biography.
If you are William Oh and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 59	2015

Other Publications

Article	Year
A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14871968	2004
Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer. Urology\| PubMed ID: 14972483	2004
The evolving role of estrogen therapy in prostate cancer. Clinical prostate cancer\| PubMed ID: 15046698	2002
To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics\| PubMed ID: 15121927	2004
Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics\| PubMed ID: 15121931	2004
Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer. Clinical prostate cancer\| PubMed ID: 15279691	2004
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15289492	2004
Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer. Current treatment options in oncology\| PubMed ID: 15341673	2004
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer. Urologic oncology\| PubMed ID: 15464919	2004
Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy. Cancer\| PubMed ID: 15468186	2004
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. The Journal of urology\| PubMed ID: 15535434	2004
An overview of chemotherapy trials in localized and recurrent nonmetastatic prostate cancer. The Journal of urology\| PubMed ID: 15535440	2004
Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. The Journal of pediatrics\| PubMed ID: 15580211	2004
Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics\| PubMed ID: 15629973	2005
A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15671557	2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic pros... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15735119	2005
Response to docetaxel/carboplatin in patients with hormone-refractory prostate cancer not responding to taxane-based chemotherapy. Clinical prostate cancer\| PubMed ID: 15992464	2005
Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development... The Pediatric infectious disease journal\| PubMed ID: 15999007	2005
Inhaled nitric oxide for premature infants with severe respiratory failure. The New England journal of medicine\| PubMed ID: 16000352	2005
Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16033841	2005
Prolonged hospital stay for extremely premature infants: risk factors, center differences, and the impact of mortality on selecting a best-performing center. Journal of perinatology : official journal of the California Perinatal Association\| PubMed ID: 16079906	2005
Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer. BJU international\| PubMed ID: 16153200	2005
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. The New England journal of medicine\| PubMed ID: 16221780	2005
Transitional cell carcinoma of the upper uroepithelial tract. Clinical advances in hematology & oncology : H&O\| PubMed ID: 16224387	2003
High-risk localized prostate cancer: integrating chemotherapy. The oncologist\| PubMed ID: 16272455	2005
A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (B... Cancer\| PubMed ID: 16329138	2006
Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. The Journal of pediatrics\| PubMed ID: 16356432	2005
Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics\| PubMed ID: 16396864	2006
Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16397037	2006
Chemotherapy for high-risk localized prostate cancer. BJU international\| PubMed ID: 16536752	2006
Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics\| PubMed ID: 16585320	2006
Recent progress in hormonal therapy for advanced prostate cancer. Current opinion in urology\| PubMed ID: 16679855	2006
Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms? Urology\| PubMed ID: 16698377	2006
Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes. Urology\| PubMed ID: 16765185	2006
Oral probiotics prevent necrotizing enterocolitis. The Journal of pediatrics\| PubMed ID: 16769410	2006
Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16782912	2006
Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16782932	2006
Carboplatin for stage I seminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16782940	2006
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer. Cancer\| PubMed ID: 16804927	2006
Development of an integrated prostate cancer research information system. Clinical genitourinary cancer\| PubMed ID: 16859581	2006
Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer. Cancer\| PubMed ID: 16862573	2006
The medical management of prostate cancer: a multidisciplinary team approach. BJU international\| PubMed ID: 16956362	2007
Effects of sample dilution, peroxidase concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns. Clinical biochemistry\| PubMed ID: 17069786	2007
Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4. The Journal of urology\| PubMed ID: 17070213	2006
Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer. Urologic oncology\| PubMed ID: 17138131	2006
Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer? Cancer\| PubMed ID: 17186531	2007
Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice. The Journal of pediatrics\| PubMed ID: 17188612	2007
Trends in neonatal morbidity and mortality for very low birthweight infants. American journal of obstetrics and gynecology\| PubMed ID: 17306659	2007
The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid. Cancer\| PubMed ID: 17311345	2007
Timing of umbilical cord clamping at birth in full-term infants. JAMA\| PubMed ID: 17374821	2007
Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer. Cancer journal (Sudbury, Mass.)\| PubMed ID: 17476141	2007
Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer. The Journal of urology\| PubMed ID: 17509304	2007
Human milk intake and retinopathy of prematurity in extremely low birth weight infants. Pediatrics\| PubMed ID: 17606555	2007
Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 17893567	2007
Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapy. Urology\| PubMed ID: 17905110	2007
Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17908974	2007
Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Cancer\| PubMed ID: 17960608	2007
Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics\| PubMed ID: 17974745	2007
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel. Cancer\| PubMed ID: 18085595	2008
Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer. BJU international\| PubMed ID: 18184327	2008
Use of androgen deprivation therapy for metastatic prostate cancer in older men. BJU international\| PubMed ID: 18190632	2008
Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18281655	2008
Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with dura... Cancer\| PubMed ID: 18293426	2008
A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones. BJU international\| PubMed ID: 18399827	2008
Association between urinary lactate to creatinine ratio and neurodevelopmental outcome in term infants with hypoxic-ischemic encephalopathy. The Journal of pediatrics\| PubMed ID: 18534246	2008
Relationship between serum adiponectin and prostate cancer grade. The Prostate\| PubMed ID: 18646046	2008
Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer. Nature clinical practice. Oncology\| PubMed ID: 18648352	2008
CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers. Human pathology\| PubMed ID: 18835619	2009
Maternal depression is a common complication among pregnant women occurring approximately 2-3% of this population. Introduction. Seminars in perinatology\| PubMed ID: 18929154	2008
What is the current status of second-line chemotherapy for castration-resistant prostate cancer? Nature clinical practice. Urology\| PubMed ID: 18936787	2008
Aggressive vs. conservative phototherapy for infants with extremely low birth weight. The New England journal of medicine\| PubMed ID: 18971491	2008
Absence of relationship between steroid hormone levels and prostate cancer tumor grade. Urology\| PubMed ID: 19036418	2009
Twin gestation and neurodevelopmental outcome in extremely low birth weight infants. Pediatrics\| PubMed ID: 19139085	2009
Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy. Cancer\| PubMed ID: 19152438	2009
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research. Clinical genitourinary cancer\| PubMed ID: 19213669	2009
Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trials. IDrugs : the investigational drugs journal\| PubMed ID: 19333896	2009
Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19366828	2009
Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19528373	2009
Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer research\| PubMed ID: 19549893	2009
Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis. Current medical research and opinion\| PubMed ID: 19586325	2009
Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS genetics\| PubMed ID: 19680443	2009
The mechanism of action of estrogen in castration-resistant prostate cancer: clues from hormone levels. Clinical genitourinary cancer\| PubMed ID: 19815485	2009
Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone. Clinical genitourinary cancer\| PubMed ID: 19815488	2009
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter st... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19826129	2009
Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review. BJU international\| PubMed ID: 19863525	2010
Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer. BJU international\| PubMed ID: 19863532	2010
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19887483	2009
Metastatic seminoma and grade 1 follicular lymphoma presenting concurrently in a supraclavicular lymph node: a case report. Cases journal\| PubMed ID: 19918516	2009
Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? Urology\| PubMed ID: 19962733	2010
Dilemmas and controversies in the management of prostate cancer continue to present a vexing challenge to physicians and patients dealing with the disease. Preface. The Urologic clinics of North America\| PubMed ID: 20152513	2010
Neoadjuvant and adjuvant therapies in prostate cancer. The Urologic clinics of North America\| PubMed ID: 20152523	2010
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted the... BJU international\| PubMed ID: 20230385	2010
Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma. Urologic oncology\| PubMed ID: 20451414	2011
Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU international\| PubMed ID: 20477822	2011
The 20th Biennial International Perinatal Collegium. Introduction. Seminars in perinatology\| PubMed ID: 20494732	2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Investigational new drugs\| PubMed ID: 20499131	2011
Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 20615892	2010
Cabazitaxel. Nature reviews. Drug discovery\| PubMed ID: 20811375	2010
Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 20855462	2010
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients. Cancer\| PubMed ID: 20862742	2011
Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcinoma in clinical practice: results from a medical chart review study. Urologic oncology\| PubMed ID: 20926319	2012
Genome-wide association study of prostate cancer mortality. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 20978177	2010
Sixty years of CA: a cancer journal for clinicians. CA: a cancer journal for clinicians\| PubMed ID: 21075954	2010
Selective cell death mediated by small conditional RNAs: a novel therapeutic approach to cancer therapy. Asian journal of andrology\| PubMed ID: 21076441	2011
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS genetics\| PubMed ID: 21085629	2010
Cancer therapy from bench to bedside. The Mount Sinai journal of medicine, New York\| PubMed ID: 21105120	2010
Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article. Journal of neurosurgery. Spine\| PubMed ID: 21121759	2010
Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21135144	2011
Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. The Journal of pediatrics\| PubMed ID: 21232766	2011
Is phototherapy exposure associated with better or worse outcomes in 501- to 1000-g-birth-weight infants? Acta paediatrica (Oslo, Norway : 1992)\| PubMed ID: 21272067	2011
Neurodevelopmental outcomes of triplets or higher-order extremely low birth weight infants. Pediatrics\| PubMed ID: 21357334	2011
Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21367958	2011
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. The Lancet. Oncology\| PubMed ID: 21376284	2011
Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatric research\| PubMed ID: 21378596	2011
Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression. Cancer\| PubMed ID: 21381010	2011
Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy. BJU international\| PubMed ID: 21410629	2011
PC3 is a cell line characteristic of prostatic small cell carcinoma. The Prostate\| PubMed ID: 21432867	2011
Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21555688	2011
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21606417	2011
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Annals of internal medicine\| PubMed ID: 21646556	2011
Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer. Clinical Medicine Insights. Oncology\| PubMed ID: 21695098	2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy. Clinical genitourinary cancer\| PubMed ID: 21700509	2011
Multicenter phase II trial of the heat shock protein 90 inhibitor, retaspimycin hydrochloride (IPI-504), in patients with castration-resistant prostate cancer. Urology\| PubMed ID: 21762967	2011
Castration-resistant prostate cancer: new science and therapeutic prospects. Therapeutic advances in medical oncology\| PubMed ID: 21789134	2010
Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. The Journal of pediatrics\| PubMed ID: 21798559	2011
The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21900597	2011
Secondary hormonal therapy in men with castration-resistant prostate cancer. Clinical genitourinary cancer\| PubMed ID: 21958520	2011
Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer. Clinical genitourinary cancer\| PubMed ID: 22130294	2012
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial. Cancer\| PubMed ID: 22282219	2012
The effects of aggressive vs. conservative phototherapy on the brainstem auditory evoked responses of extremely-low-birth-weight infants. Pediatric research\| PubMed ID: 22289854	2012
Hemodynamic effects of delayed cord clamping in premature infants. Pediatrics\| PubMed ID: 22331336	2012
Overcoming castration resistance in prostate cancer. Current opinion in urology\| PubMed ID: 22472508	2012
Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes. CA: a cancer journal for clinicians\| PubMed ID: 22535487	2012
The emerging role of circulating tumor cell detection in genitourinary cancer. The Journal of urology\| PubMed ID: 22578722	2012
Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World journal of urology\| PubMed ID: 22622394	2013
Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: a meta-analysis. Cancer treatment reviews\| PubMed ID: 22651902	2012
Trends in the use of cytoreductive nephrectomy in the United States. Clinical genitourinary cancer\| PubMed ID: 22651971	2012
Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18-22 months corrected age. Archives of disease in childhood. Fetal and neonatal edition\| PubMed ID: 22684157	2013
Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy. Cancer\| PubMed ID: 22707387	2012
Bevacizumab treatment of prostate cancer. Expert opinion on biological therapy\| PubMed ID: 22775507	2012
Atypical metastases from prostate cancer: 10-year experience at a single institution. AJR. American journal of roentgenology\| PubMed ID: 22826398	2012
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer. BJU international\| PubMed ID: 22928480	2012
Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC). BJU international\| PubMed ID: 22985411	2012
Urological cancer: Enzalutamide in metastatic CRPC-old dog, new tricks. Nature reviews. Clinical oncology\| PubMed ID: 23044775	2012
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study. The Lancet. Oncology\| PubMed ID: 23059047	2012
Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis. Journal of the National Cancer Institute\| PubMed ID: 23093559	2012
Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23150697	2012
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis. World journal of urology\| PubMed ID: 23223962	2013
Emerging personalized approaches for the management of advanced urothelial carcinoma. Expert review of anticancer therapy\| PubMed ID: 23253220	2012
Fluid and electrolyte management of very low birth weight infants. Pediatrics and neonatology\| PubMed ID: 23276435	2012
Early onset neonatal group B streptococcal sepsis. American journal of perinatology\| PubMed ID: 23322392	2013
Vitamin A Supplementation in Extremely Low-Birth-Weight Infants: Subgroup Analysis in Small-for-Gestational-Age Infants. American journal of perinatology\| PubMed ID: 23329565	2013
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer. Urologic oncology\| PubMed ID: 23428534	2014
Indomethacin prophylaxis to prevent intraventricular hemorrhage: association between incidence and timing of drug administration. The Journal of pediatrics\| PubMed ID: 23522865	2013
Metabolic and toxicological considerations of newly approved prostate cancer drugs. Expert opinion on drug metabolism & toxicology\| PubMed ID: 23581700	2013
New paradigms in microtubule-mediated endocrine signaling in prostate cancer. Molecular cancer therapeutics\| PubMed ID: 23635655	2013
Cord milking at delivery improves the iron status of term infants at 6 weeks. Evidence-based medicine\| PubMed ID: 23645906	2013
Castration-resistant prostate cancer: AUA Guideline. The Journal of urology\| PubMed ID: 23665272	2013
The impact of gender on outcomes in patients with metastatic urothelial carcinoma. Clinical genitourinary cancer\| PubMed ID: 23673281	2013
Metabolic complications with the use of mTOR inhibitors for cancer therapy. Cancer treatment reviews\| PubMed ID: 23684373	2014
Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy. Cancer\| PubMed ID: 23720197	2013
Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy. Cancer\| PubMed ID: 23720216	2013
Tumour angiogenesis: an elusive target in castration-resistant prostate cancer. The Lancet. Oncology\| PubMed ID: 23742876	2013
Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis. Targeted oncology\| PubMed ID: 23852656	2014
Behavioral and socioemotional competence problems of extremely low birth weight children. Journal of perinatology : official journal of the California Perinatal Association\| PubMed ID: 23867957	2013
Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight in... The Journal of pediatrics\| PubMed ID: 23992673	2014
Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy. Urologic oncology\| PubMed ID: 24055428	2014
Not all "term" infants are created equal. JAMA pediatrics\| PubMed ID: 24080941	2013
TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression. PloS one\| PubMed ID: 24143225	2013
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review. International journal of oncology\| PubMed ID: 24247547	2014
Perfusion imaging of spinal cord contusion: injury-induced blockade and partial reversal by β2-agonist treatment in rats. Journal of neurosurgery. Spine\| PubMed ID: 24313676	2014
Adverse event reporting in cancer clinical trial publications. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 24323037	2014
Is metastatic prostate cancer changing, and how will we know it? It's time for standard nomenclature for nonosseous metastases in clinical trials of patients with metastatic castration resis... European urology\| PubMed ID: 24433812	2014
Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials. Critical reviews in oncology/hematology\| PubMed ID: 24500033	2014
Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II-III Resectable Disease. The Journal of investigative dermatology\| PubMed ID: 24522433	2014
Blood mRNA expression profiling predicts survival in patients treated with tremelimumab. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 24721645	2014
The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions. Asian journal of andrology\| PubMed ID: 24759585	2014
T2 muscle-invasive bladder cancer. Seminars in oncology\| PubMed ID: 24787300	2014
Effects of placental transfusion in extremely low birthweight infants: meta-analysis of long- and short-term outcomes. Transfusion\| PubMed ID: 24843886	2014
The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer. Therapeutic advances in urology\| PubMed ID: 24883107	2014
Mind the gap: efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics. Cancer\| PubMed ID: 24965362	2014
Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers\| PubMed ID: 24978435	2014
Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors. Cancer chemotherapy and pharmacology\| PubMed ID: 25023489	2014
Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC). BJU international\| PubMed ID: 25046451	2015
Phase Ib/II trial of gemcitabine, cisplatin, and lenalidomide as first-line therapy in patients with metastatic urothelial carcinoma. The oncologist\| PubMed ID: 25052451	2014
Adult cancer clinical trials that fail to complete: an epidemic? Journal of the National Cancer Institute\| PubMed ID: 25190726	2014
Use of crowdsourcing for cancer clinical trial development. Journal of the National Cancer Institute\| PubMed ID: 25217580	2014
Is prostate cancer changing?: evolving patterns of metastatic castration-resistant prostate cancer. Cancer\| PubMed ID: 25302607	2014
Geographic accessibility to clinical trials for advanced cancer in the United States. JAMA internal medicine\| PubMed ID: 25437434	2015
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer. Clinical genitourinary cancer\| PubMed ID: 25450031	2015
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer. Investigational new drugs\| PubMed ID: 25556680	2015
Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer. The Prostate\| PubMed ID: 25560638	2015
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease. The Journal of urology\| PubMed ID: 25623747	2015
The Impact of Regionalization of Cystectomy on Racial Disparities in Bladder Cancer Care. The Journal of urology\| PubMed ID: 25623748	2015
Clinical trial awareness: Changes over time and sociodemographic disparities. Clinical trials (London, England)\| PubMed ID: 25673636	2015
Systemic therapy for the treatment of hormone-sensitive metastatic prostate cancer: from intermittent androgen deprivation therapy to chemotherapy. Current urology reports\| PubMed ID: 25677235	2015
Urological cancer: Is docetaxel the 'black widow' of mCRPC drugs? Nature reviews. Clinical oncology\| PubMed ID: 25917253	2015
Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer. Frontiers in oncology\| PubMed ID: 26125012	2015
A robust blood gene expression-based prognostic model for castration-resistant prostate cancer. BMC medicine\| PubMed ID: 26297150	2015
Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma. Cancer chemotherapy and pharmacology\| PubMed ID: 26464352	2015